Lack of Commercial Oral Drug Formulations for Children in Two Hospital Group Purchasing Agreements in France and Canada
Author(s): Prot-Labarthe Sonia, Bussieres Jean-Francois, Barett Pierre, Bourdon Olivier, Brion Francoise
Issue: Jul/Aug 2008 - Hormone Replacement Therapy
View All Articles in Issue
Page(s): 365-367
Download in electronic PDF format for $65
Abstract: There are a limited number of commercial oral pediatric drug formulations on the market. The incidence of available commercial oral formulations for children has not been studied to date. This study compared the number and the characteristics of oral pediatric drug formulations listed on two hospital group purchasing agreements for the two large urban areas (e.g., Paris and Montreal), valid on April 1, 2006. Variables collected were the brand and the generic name product, the anatomical therapeutic chemical classification, the drug formulation, and the dispensing tool. Throughout this study, we identified that there was a total of 191 and 151 commercial oral pediatric drug formulations corresponding to 127 and 94 generic name products, respectively in Paris and Montreal. The three main anatomical therapeutic chemical classification classes are alimentary tract and metabolism drugs, systemic anti-infectives, and drugs acting on nervous system. There are only 47 generic names common to both group purchasing agr
Related Keywords: Sonia Prof-LaBarthe, DPharm, PhD, Jean-Francois Bussieres, BPharm, MSc, MBA, CSHP, Pierre Barret, Olivier Bourdon, DPharm, PhD, MBA, Francoise Brion, DPharm, PhD, children, hospital pharmacy, oral formulations, Canada, France, dosage forms
Related Categories: LEGAL, PEDIATRICS, PEER-REVIEWED, DOSAGE FORMS/DRUG CARRIERS